Patents by Inventor Susan J. Clark

Susan J. Clark has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ASSAY FOR METHYLATION IN THE GST-PI GENE
    Publication number: 20120231452
    Abstract: A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.
    Type: Application
    Filed: November 30, 2011
    Publication date: September 13, 2012
    Applicant: Commonwealth Scientific and Industrial Research Organisation
    Inventors: Susan J. Clark, Douglas S. Millar, Peter L. Molloy
  • Assay for methylation in the GST-Pi gene
    Patent number: 8088577
    Abstract: A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.
    Type: Grant
    Filed: October 28, 2008
    Date of Patent: January 3, 2012
    Assignee: Commonwealth Scientific and Industrial Research Organisation
    Inventors: Susan J. Clark, Douglas S. Millar, Peter L. Molloy
  • Assay for Methylation in the GST-PI Gene
    Publication number: 20090215056
    Abstract: A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.
    Type: Application
    Filed: October 28, 2008
    Publication date: August 27, 2009
    Applicant: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
    Inventors: SUSAN J. CLARK, DOUGLAS S. MILLAR, PETER L. MOLLOY
  • Assay for methylation in the GST-Pi gene
    Patent number: 7049062
    Abstract: A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.
    Type: Grant
    Filed: April 23, 1999
    Date of Patent: May 23, 2006
    Assignee: Commonwealth Scientific and Industrial Research Organisation
    Inventors: Susan J. Clark, Douglas S. Millar, Peter L. Molloy